Literature DB >> 9039456

On the question of apoptosis in the parkinsonian substantia nigra.

S Kösel1, R Egensperger, U von Eitzen, P Mehraein, M B Graeber.   

Abstract

Apoptosis has been postulated as a mechanism of nerve cell death in Parkinson's disease. In the present study, the substantia nigra of 22 neuropathologically confirmed Parkinson cases and 8 control brains was studied using the in situ end-labeling (TUNEL) method. About 50% of parkinsonian brains showed a small number of TUNEL-positive glial cells in the substantia nigra, whereas no neurons showed convincing TUNEL positivity or any morphological signs of apoptosis. No correlation was observed between the number of TUNEL-positive glial cells and microglial activation. Our results fail to demonstrate apoptosis as a mechanism of cell death in Parkinson's disease.

Entities:  

Mesh:

Year:  1997        PMID: 9039456     DOI: 10.1007/s004010050590

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

Review 1.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson; Paramita Chakrabarty
Journal:  Acta Neuropathol       Date:  2019-02-23       Impact factor: 17.088

Review 2.  Can calcium antagonists provide a neuroprotective effect in Parkinson's disease?

Authors:  R L Rodnitzky
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

3.  An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.

Authors:  H Mochizuki; H Hayakawa; M Migita; M Shibata; R Tanaka; A Suzuki; Y Shimo-Nakanishi; T Urabe; M Yamada; K Tamayose; T Shimada; M Miura; Y Mizuno
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

4.  Multiplex three-dimensional brain gene expression mapping in a mouse model of Parkinson's disease.

Authors:  Vanessa M Brown; Alex Ossadtchi; Arshad H Khan; Simon Yee; Goran Lacan; William P Melega; Simon R Cherry; Richard M Leahy; Desmond J Smith
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

5.  α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.

Authors:  Neda Saffarian Tousi; Daniel J Buck; J Thomas Curtis; Randall L Davis
Journal:  Neurosci Lett       Date:  2011-12-13       Impact factor: 3.046

Review 6.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Overexpression of α-Synuclein Reorganises Growth Factor Profile of Human Astrocytes.

Authors:  Büşra Şengül; Erdinç Dursun; Alexei Verkhratsky; Duygu Gezen-Ak
Journal:  Mol Neurobiol       Date:  2020-09-10       Impact factor: 5.590

8.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

Authors:  L Yang; R T Matthews; J B Schulz; T Klockgether; A W Liao; J C Martinou; J B Penney; B T Hyman; M F Beal
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.

Authors:  L B Moran; D C Duke; M Deprez; D T Dexter; R K B Pearce; M B Graeber
Journal:  Neurogenetics       Date:  2006-01-12       Impact factor: 2.660

Review 10.  Crashing the computer: apoptosis vs. necroptosis in neuroinflammation.

Authors:  Bradlee L Heckmann; Bart Tummers; Douglas R Green
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.